Archive
Home / Media Centre / Archive
Here you can find the archive of all Press Releases prior to 2023
Filter by date:
Showing 1239 press releases before 2023
-
Capivasertib plus Faslodex significantly improved progression-free survival vs. Faslodex in CAPItello-291 Phase III trial in advanced HR-positive breast cancer
-
Update on the MESSINA Phase III trial for Fasenra in eosinophilic esophagitis
-
Imjudo (tremelimumab) in combination with Imfinzi approved in the US for patients with unresectable liver cancer
-
IDWeek data reinforces AstraZeneca’s commitment to advance science in vaccines and immune therapies
-
Alexion aims to advance NMOSD treatment landscape with exceptional Ultomiris efficacy data at ECTRIMS 2022
-
Koselugo approved in Japan for paediatric patients with plexiform neurofibromas in neurofibromatosis type1
-
Tezspire approved in Japan for the treatment of severe asthma
-
Ultomiris approved in Europe for the treatment of adults with generalised myasthenia gravis
-
Lynparza approved in China as 1st-line maintenance treatment with bevacizumab for HRD-positive advanced ovarian cancer
-
Tezspire approved in the EU for the treatment of severe asthma
Latest articles and press releases
All of our latest press releases and articles are available to explore
